Growth of 40% per annum continues for AFT Pharmaceuticals in the Australasian market (Australia and NZ) with sales for this year due to break $22 million per annum.
AFT Group Sales Growth continues at +40%
Similar articles
AFT picks up Supreme Business award
A Takapuna-based drug company claimed top honours at the 2011 Westpac Auckland North Business Awards at the competition’s annual Gala Dinner held last night.
Read more
AFT builds North American momentum
Diversified pharmaceutical company appoints new north American-based director and launches Maxigesic® in Canada.
Read more
AFT Pharmaceuticals Strengthens Asian Operations
AFT Pharmaceuticals (AFT) is continuing to build its business operations in South East Asia by moving to the appointment of a Business Manager based in its Kuala Lumpur office in Malaysia.
Read more